QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dentin, R. Articles by Postic, C. Search for Related Content PubMed PubMed Citation Articles by Dentin, R. Articles by Postic, C.

---

Critical Review

Hepatic Gene Regulation by Glucose and Polyunsaturated Fatty Acids: A Role for ChREBP

Institut Cochin, INSERM U567 CNRS UMR8104, Université René Descartes, Département d'Endocrinologie, Métabolisme et Cancer, Paris, France

¹ To whom correspondence should be addressed. E-mail: postic{at}cochin.inserm.fr.

The liver is a major site for carbohydrate metabolism (glycolysis and glycogen synthesis) and triglyceride synthesis (lipogenesis). In the last decade, increasing evidence has emerged to show that nutrients, in particular, glucose and fatty acids, are able to regulate hepatic gene expression in a transcriptional manner. Indeed, although insulin was long thought to be the major regulator of hepatic gene expression, it is now clear that glucose metabolism rather that glucose itself also contributes substantially to the coordinated regulation of carbohydrate and lipid homeostasis in liver. In fact, the recent discovery of the glucose-signaling transcription factor carbohydrate responsive element binding protein (ChREBP) shed some light on the molecular mechanisms by which glycolytic and lipogenic genes are reciprocally regulated by glucose and fatty acids in liver. Here, we will review some of the recent studies that have begun to elucidate the regulation and function of this key transcription factor in liver. Indeed, a better understanding of the mechanisms by which glucose and fatty acids control hepatic gene expression may provide novel insight into the development of new therapeutic strategies for a better management of diseases involving blood glucose and/or disorders of lipid metabolism.

KEY WORDS: • ChREBP • glucose • polyunsaturated fatty acids • transcriptional regulation • glycolytic and lipogenic gene expression

This article has been cited by other articles:

				J. N. Baumgardner, K. Shankar, L. Hennings, T. M. Badger, and M. J. J. Ronis A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G27 - G38. [Abstract] [Full Text] [PDF]

				M. Ranalletta, X. Q. Du, Y. Seki, A. S. Glenn, M. Kruse, A. Fiallo, I. Estrada, T.-S. Tsao, A. E. Stenbit, E. B. Katz, et al. Hepatic response to restoration of GLUT4 in skeletal muscle of GLUT4 null mice Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1178 - E1187. [Abstract] [Full Text] [PDF]

				N. Marty, M. Dallaporta, and B. Thorens Brain Glucose Sensing, Counterregulation, and Energy Homeostasis Physiology, August 1, 2007; 22(4): 241 - 251. [Abstract] [Full Text] [PDF]

				L. Li, M. Naples, H. Song, R. Yuan, F. Ye, S. Shafi, K. Adeli, and D. S. Ng LCAT-null mice develop improved hepatic insulin sensitivity through altered regulation of transcription factors and suppressors of cytokine signaling Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E587 - E594. [Abstract] [Full Text] [PDF]

				J. Jason Collier, P. Zhang, K. B. Pedersen, S. J. Burke, J. W. Haycock, and D. K. Scott c-Myc and ChREBP regulate glucose-mediated expression of the L-type pyruvate kinase gene in INS-1-derived 832/13 cells Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E48 - E56. [Abstract] [Full Text] [PDF]